CUSIP 02043QAB3NOTE 1.000% 9/1ALNYQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
11 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Amundi | 5.00M | $735.15M | +5.00M | New |
| 2 | Boussard & Gavaudan Investment Management LLP | 21.0K | $30.92M | +7.9K | Added |
| 3 | State Of Wisconsin Investment Board | 3.00M | $4.41M | 0 | Held |
| 4 | Loomis Sayles & Co L P | 9.0K | $3.60M |
| +9.0K |
| New |
| 5 | Sei Investments Co | 251.0K | $369.0K | 0 | Held |
| 6 | Oppenheimer Asset Management Inc. | 82.0K | $120.6K | −1.0K | Reduced |
| 7 | Stephens Inc /Ar/ | 24.0K | $35.3K | 0 | Held |
| 8 | Mml Investors Services, LLC | 10.0K | $14.7K | +10.0K | New |
| 9 | Newedge Advisors, LLC | 10.0K | $14.7K | +10.0K | New |
| 10 | Bnp Paribas Asset Management Holding S.A. | 4.75M | $7.0K | +4.75M | New |
See every fund holding Alnylam Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders